<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04530773</url>
  </required_header>
  <id_info>
    <org_study_id>2020KYPJ092</org_study_id>
    <nct_id>NCT04530773</nct_id>
  </id_info>
  <brief_title>Key Evaluation Techniques and Criteria of Visual Health in Virtual Reality</brief_title>
  <official_title>The Core Evaluation Indexes and Correlation Between Technical Parameters and Visual Health Indicators in Different Types of Virtual Reality Products</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhongshan Ophthalmic Center, Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhongshan Ophthalmic Center, Sun Yat-sen University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      China's VR industry is booming, but it also faces many problems. At present, industry&#xD;
      standards for key physical parameters of virtual reality are still being explored. More and&#xD;
      more attention has been paid to the visual health and safety of VR. Based on&#xD;
      ophthalmology-neurologic technology, this study screened VR ocular safety parameters,&#xD;
      constructed VR evaluation model and provided visual health evaluation system and standards&#xD;
      for VR technology.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accommodative Response</measure>
    <time_frame>60 min</time_frame>
    <description>The actual amount of accommodation that exists is measured with a skiascope</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AC/A Ratio</measure>
    <time_frame>60 min</time_frame>
    <description>The ratio of accommodation convergence to accommodation is measured and calculated by maddox</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Visual Health of Virtual Reality</condition>
  <arm_group>
    <arm_group_label>GROUP1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Watch VR movies/ Play VR games</intervention_name>
    <description>The healthy individuals will watch VR movies or play VR games with different Physical parameters for 60 minutes.</description>
    <arm_group_label>GROUP1</arm_group_label>
    <arm_group_label>GROUP2</arm_group_label>
    <arm_group_label>GROUP3</arm_group_label>
    <arm_group_label>GROUP4</arm_group_label>
    <arm_group_label>GROUP5</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The study included healthy individuals older than 18 years of age with a&#xD;
             best-corrected visual acuity (BCVA) of &lt;0.1 logarithm of minimum angle of resolution&#xD;
             (logMAR) and no ongoing or prior history of ocular or systemic disease.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The study excluded healthy individuals younger than 18 years of age with a&#xD;
             best-corrected visual acuity (BCVA) of &gt;0.1 logarithm of minimum angle of resolution&#xD;
             (logMAR) with ongoing or prior history of ocular or systemic disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yiyao Wang, PHD</last_name>
    <phone>13600046064</phone>
    <email>yaoyaoyatou42@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jin Yuan, PHD</last_name>
    <phone>13825141659</phone>
    <email>yuanjincornea@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongshan Opthalmic Center</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Jin Yuan, PHD</last_name>
      <phone>13825141659</phone>
      <email>yuanjincornea@126.com</email>
    </contact>
    <investigator>
      <last_name>Jin Yuan, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 24, 2020</study_first_submitted>
  <study_first_submitted_qc>August 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2020</study_first_posted>
  <last_update_submitted>August 27, 2020</last_update_submitted>
  <last_update_submitted_qc>August 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Jin Yuan</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

